Motley Fool Australia
  •  
  • Log Out
  • Menu
Home / Sector / Healthcare Shares / The Cochlear Limited share price just hit a 52 week high

The Cochlear Limited share price just hit a 52 week high

The Cochlear share price is on the move

Posted by
Motley Fool Staff ❯
@TheMotleyFoolAu
The articles listed on this page are compiled by our team of Foolish Writers and Editors. They contain opinions that may differ from The Motley Fool’s Premium Investing Services.
Published
| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Cochlear Limited (ASX: COH) share price has today hit a 52-week high, trading as high as $155.30.

This latest gain means that the bionic ear company's shares have provided shareholders with a year-to-date return of over 26%.

At an investor day last month, Cochlear management reiterated its full-year earnings guidance of between $210 million and $225 million, an increase of between 10% and 20% on last year's result.

Cochlear shares are not exactly cheap, trading at around 40 times forward earnings estimates.

Motley Fool contributor Motley Fool Staff has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Happy healthcare workers in a labs
Healthcare Shares

Macquarie initiates coverage of Neuren Pharmaceuticals shares; forecasts 45% upside

| Laura Stewart

The broker described Neuren as a standout in the ASX biotech sector.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Healthcare Shares

Does Macquarie think Cochlear shares are a buy, hold, or sell?

| Bronwyn Allen

Macquarie has released a new note on Cochlear following the company's FY25 profit guidance change.

Read more »

Stethoscope with a piggy bank in the middle.
Healthcare Shares

Up 18% this year, does Macquarie expect NIB shares to go higher?

| Sebastian Bowen

This expert has a bold prediction for NIB.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why is the Mesoblast share price up 11% in June?

| Bronwyn Allen

The ASX biotech share reached a 10-week high of $1.94 today.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Up 51% since the tariff pain, is it too late to buy Pro Medicus shares?

| Tristan Harrison

After rocketing higher, is the ASX healthcare share still an opportunity?

Read more »

A woman wearing a yellow shirt smiles as she checks her phone.
Healthcare Shares

CSL shares push higher on US FDA approval

| James Mickleboro

This biotech giant has been given a boost in the United States.

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Up 29% this year, does Macquarie expect Medibank Private shares to continue rising?

| Sebastian Bowen

Medibank's explosive share price growth has caught the eye of this broker.

Read more »

Man in business suit carries box of personal effects
Healthcare Shares

Monash IVF shares jump 9% as CEO quits after second embryo incident

| James Mickleboro

Two incidents at its clinics have cost this CEO his job.

Read more »